Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status
Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received ‘fast track’ designation from the U.S. health agency, speeding up the regulatory review process.
- Region:
- World
- Category:
- Technology
- Author/s:
- By Reuters
